Loading company…
Quantum Intelligence develops an AI platform to support early-stage drug discovery.
Founded in 2020 and based in Seoul, South Korea, Quantum Intelligence operates QUEST, a neural network platform that optimizes drug candidates and predicts chemical properties without wet trials. It uses a three-dimensional electrostatic potential method derived from quantum physics. The company was founded by Hwanho Choi, Hongsuk Kang, Hojeong Pak, Sangwon Rhie and Yoojeong Cha.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in